Quest Diagnostics, headquartered in Secaucus, New Jersey, employs 40,000 staff and provides diagnostic testing services to physicians, hospitals, and patients through a nationwide network. The company utilizes AI and digital solutions to enhance laboratory functions and support biopharmaceutical companies.
Mark E Delaney sold 874 shares of DGX on 13 May at $175.31 per share, worth a total of $153K. They now own 7,498 DGX shares, or a 10% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
